Miravant files photodynamic therapy for AMD (age-related macular degeneration) in the US
This article was originally published in Clinica
Executive Summary
Miravant Medical Technologies has filed a US marketing application for its PhotoPoint photodynamic therapy (PDT) for wet age-related macular degeneration (AMD).